SI9110908A - Inkluzijski kompleksi N-etoksikarbonil-3-morfolino-sidnonimina ali soli tvorjeni z derivati ciklodekstrina, njihovo pridobivanje in farmacevtski pripravki, ki jih vsebujejo - Google Patents

Inkluzijski kompleksi N-etoksikarbonil-3-morfolino-sidnonimina ali soli tvorjeni z derivati ciklodekstrina, njihovo pridobivanje in farmacevtski pripravki, ki jih vsebujejo Download PDF

Info

Publication number
SI9110908A
SI9110908A SI9110908A SI9110908A SI9110908A SI 9110908 A SI9110908 A SI 9110908A SI 9110908 A SI9110908 A SI 9110908A SI 9110908 A SI9110908 A SI 9110908A SI 9110908 A SI9110908 A SI 9110908A
Authority
SI
Slovenia
Prior art keywords
cyclodextrin
beta
ethoxycarbonyl
morpholino
salt
Prior art date
Application number
SI9110908A
Other languages
English (en)
Slovenian (sl)
Inventor
Maria Vikmon
Jozsef Szejtli
Jozsef Gaal
Istvan Hermecz
Agnes Horvath
Katalin Marmarosi
Gabor Horvath
Iren Munkasci
Original Assignee
Therabel Industries S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therabel Industries S.A. filed Critical Therabel Industries S.A.
Priority claimed from YU90891A external-priority patent/YU48330B/sh
Publication of SI9110908A publication Critical patent/SI9110908A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI9110908A 1990-03-28 1991-03-28 Inkluzijski kompleksi N-etoksikarbonil-3-morfolino-sidnonimina ali soli tvorjeni z derivati ciklodekstrina, njihovo pridobivanje in farmacevtski pripravki, ki jih vsebujejo SI9110908A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU901868A HU210921B (en) 1990-03-28 1990-03-28 Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
YU90891A YU48330B (sh) 1990-03-28 1991-03-28 Inkluzioni kompleksi n-etoksikarb onil-3-morfolino-sidnonimina ili soli nagr ađene sa derivatima ciklodekstrina njihovo dobijanje i farmaceutski preparati koji sadrže iste

Publications (1)

Publication Number Publication Date
SI9110908A true SI9110908A (sl) 1998-06-30

Family

ID=10956592

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9110908A SI9110908A (sl) 1990-03-28 1991-03-28 Inkluzijski kompleksi N-etoksikarbonil-3-morfolino-sidnonimina ali soli tvorjeni z derivati ciklodekstrina, njihovo pridobivanje in farmacevtski pripravki, ki jih vsebujejo

Country Status (34)

Country Link
US (1) US5403840A (he)
EP (1) EP0477315B1 (he)
JP (1) JP2582497B2 (he)
KR (1) KR950004705B1 (he)
CN (1) CN1051080C (he)
AT (1) ATE138656T1 (he)
AU (1) AU638824B2 (he)
BG (1) BG61689B1 (he)
BR (1) BR9105136A (he)
CA (1) CA2054188C (he)
CZ (1) CZ287353B6 (he)
DE (1) DE69119853T2 (he)
DK (1) DK0477315T3 (he)
ES (1) ES2090320T3 (he)
FI (1) FI102460B (he)
GE (1) GEP19991832B (he)
GR (1) GR3020684T3 (he)
HR (1) HRP920561B1 (he)
HU (1) HU210921B (he)
IL (1) IL97714A (he)
LT (1) LT3394B (he)
LV (1) LV10245B (he)
MC (1) MC2185A1 (he)
MD (1) MD679G2 (he)
NO (1) NO179611C (he)
OA (1) OA10029A (he)
PL (1) PL165868B1 (he)
RO (1) RO109649B1 (he)
RU (1) RU2111216C1 (he)
SI (1) SI9110908A (he)
SK (1) SK279891B6 (he)
TJ (1) TJ231R3 (he)
UA (1) UA27226C2 (he)
WO (1) WO1991014680A1 (he)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA949182B (en) * 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
GB2290964A (en) * 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine
ITTO20120056A1 (it) * 2012-01-24 2013-07-25 Borla Ind Connettore per linee medicali di infusione, trasfusione e simili
ITTO20130433A1 (it) * 2013-05-29 2014-11-30 Borla Ind Connettore per linee medicali
BE1028879B1 (fr) 2020-12-11 2022-07-12 Europharmaceuticals Comprimé à libération prolongée de la molsidomine

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695897C3 (de) * 1966-07-04 1979-02-15 Takeda Chemical Industries Ltd N-Acyl-sydnonimine, deren Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3221425A1 (de) * 1982-06-07 1983-12-08 Boehringer Ingelheim KG, 6507 Ingelheim Hydrolyseempfindlichen wirkstoff enthaltende, lagerstabile tablette
DK243084A (da) 1983-05-26 1984-11-27 Takeda Chemical Industries Ltd Perkutane farmaceutiske praeparater til udvortes brug
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
DE3522191A1 (de) * 1985-06-21 1987-01-15 Cassella Ag Photostabilisierung von sydnoniminen
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPH0819004B2 (ja) * 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
IT1204725B (it) * 1987-06-17 1989-03-10 Edmond Pharma Srl Complessi di inclusione del dipiridamolo con ciclodestrine
DE68901043D1 (de) * 1988-01-14 1992-04-30 Akzo Nv Waessriges pharmazeutisches praeparat.
US5120732A (en) * 1988-06-14 1992-06-09 Cassella Aktiengesellschaft Substituted 3-aminosyndone imines, a process for their preparation and their use
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
HU211648A9 (en) * 1990-03-28 1995-12-28 Chinoin Gyogyszer Es Vegyeszet Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
CA2054188A1 (en) 1991-09-29
NO179611B (no) 1996-08-05
KR950004705B1 (ko) 1995-05-04
ES2090320T3 (es) 1996-10-16
HRP920561A2 (hr) 1994-04-30
CS85191A3 (en) 1991-11-12
HRP920561B1 (en) 1999-12-31
IL97714A0 (en) 1992-06-21
LTIP386A (en) 1994-12-27
NO914649L (no) 1991-11-27
CN1056688A (zh) 1991-12-04
HUT58109A (en) 1992-01-28
LV10245B (en) 1995-08-20
MD679F1 (en) 1997-02-28
PL165868B1 (pl) 1995-02-28
KR920701182A (ko) 1992-08-11
AU638824B2 (en) 1993-07-08
FI915569A0 (fi) 1991-11-26
JPH04506362A (ja) 1992-11-05
CA2054188C (en) 1996-07-23
UA27226C2 (uk) 2000-08-15
OA10029A (en) 1996-10-14
US5403840A (en) 1995-04-04
HU901868D0 (en) 1990-08-28
WO1991014680A1 (en) 1991-10-03
EP0477315A1 (en) 1992-04-01
JP2582497B2 (ja) 1997-02-19
RU2111216C1 (ru) 1998-05-20
FI102460B1 (fi) 1998-12-15
MD679G2 (ro) 1997-11-30
DK0477315T3 (da) 1996-09-30
DE69119853D1 (de) 1996-07-04
AU7574591A (en) 1991-10-21
TJ231R3 (en) 1999-11-24
NO179611C (no) 1996-11-13
CZ287353B6 (cs) 2000-11-15
ATE138656T1 (de) 1996-06-15
MC2185A1 (fr) 1992-09-16
EP0477315B1 (en) 1996-05-29
CN1051080C (zh) 2000-04-05
IL97714A (he) 1995-03-30
GR3020684T3 (en) 1996-10-31
GEP19991832B (en) 1999-11-05
DE69119853T2 (de) 1996-10-10
FI102460B (fi) 1998-12-15
RO109649B1 (ro) 1995-04-28
LV10245A (lv) 1994-10-20
HU210921B (en) 1995-09-28
LT3394B (en) 1995-09-25
NO914649D0 (no) 1991-11-27
PL293022A1 (en) 1992-12-28
SK279891B6 (sk) 1999-05-07
BG61689B1 (bg) 1998-03-31
BR9105136A (pt) 1992-08-04
BG95531A (bg) 1993-12-24

Similar Documents

Publication Publication Date Title
KR101275372B1 (ko) 에스트로겐-시클로덱스트린 복합체의 조성물
US5244881A (en) Compositions based on imipyramine
JPH0819004B2 (ja) 徐放性医薬製剤
US4518588A (en) Process for the preparation of an inclusion complex of N-(1--phenylethyl)-3,3-diphenylpropylamine and the hydrochloride thereof respectively with cyclodextrin
JPS5837284B2 (ja) セイヤクソセイブツノセイホウ
KR100237719B1 (ko) 플루로머틸린 착체 및 이를 함유하는 약제학적 제제
SI9110908A (sl) Inkluzijski kompleksi N-etoksikarbonil-3-morfolino-sidnonimina ali soli tvorjeni z derivati ciklodekstrina, njihovo pridobivanje in farmacevtski pripravki, ki jih vsebujejo
JPH04506221A (ja) ３―モルホリノ―シドノンイミン又はその塩又はその互変異性体の包接錯体、その製法、及び該包接錯体を含有する医薬組成物
WO1999020276A1 (fr) Composition medicamenteuse stable
HUT72055A (en) Ciklodextrin-vinpocetin complexes process for producing them and pharmaceutical compositions containing them
JPS60255724A (ja) ニフエジピン配合調製物
JPH01287094A (ja) ダナゾール−シクロデキストリン包接化合物
KR960003605B1 (ko) 경구용 오메프라졸 약제의 코어 조성물을 제조하는 방법
HU211906A9 (en) Inclusion complexes of n-ethoxycarbonyl 1-3-morpholino-sydnonimine or salts formed with cyclodextrin-derivatives, preparation thereof and pharmaceutical compositions containing the same
Rajkumar Preparation and Evaluation of Cyclodextrin Inclusion Complexes of Water Insoluble Drug Gliclazide